News
![engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering](https://pharmaphorum.com/wp-content/uploads/2018/12/wednesday-image.jpg)
UCB revs up its gene therapy drive with Handl acquisition
UCB has made a new foray into the gene therapy space, buying fellow Belgium-based company Handl to get control of its adeno-associated virus (AAV) capsid delivery platform and two research